Assisted Reproduction in Congenital Adrenal Hyperplasia
- PMID: 31708872
- PMCID: PMC6819309
- DOI: 10.3389/fendo.2019.00723
Assisted Reproduction in Congenital Adrenal Hyperplasia
Abstract
Congenital Adrenal Hyperplasia (CAH) is a group of autosomal recessive disorders characterized by defects of adrenal steroidogenesis due to mutations in one of the following enzymes: 21-hydroxylase (21OH), 11β-hydroxylase (11βOH), 17α-hydroxylase (17OH; also known as 17, 20-lyase), 3β hydroxysteroid dehydrogenase type 2 (3βHSD2), steroidogenic acute regulatory protein (StAR), P450 cholesterol side-chain cleavage (P450scc), and P450 oxidoreductase (POR). More than 95% of congenital adrenal hyperplasia cases are due to mutations in CYP21A2, the gene encoding the adrenal steroid 21-hydroxylase enzyme (P450c21). This work focuses on this type of CAH given that it is the most frequent one. This disease is characterized by impaired cortisol and aldosterone production as well as androgen excess. A variant of the CAH is the non-classic type of CAH (NCCAH), usually asymptomatic before the 5th year of age, diagnosed during puberty especially in patients visiting a fertility clinic. NCCAH is characterized mainly by anovulatory cycles and/or high androgen concentrations. Both types of CAH are associated with infertility. Given that the incidence of NCCAH is greater than that of CAH, patients suffering from NCCAH are more often diagnosed for the first time in a fertility clinic. Thus, screening for NCCAH should always be considered. The causes of infertility in CAH patients are multi-factorial including virilization of external genitalia, altered psychosocial development, and hormonal disorders. The main challenges encountered in assisted reproduction are the androgen excess-associated anovulatory cycles as well as the increased circulating progesterone concentrations during the follicular phase which impact endometrial receptivity, tubal motility, and cervical thickness. Administration of sufficient substitution dose of glucocorticoids usually resolves these problems and leads not only to successful assisted reproduction treatment but also to spontaneous pregnancy. Patients with CAH should be followed by a multidisciplinary team including gynecologist, endocrinologist, and pediatrician.
Keywords: IVF (in vitro fertilization); assisted reproduction (ART); congenital adrenal hyperplasia (CAH); infertility; pregnancy.
Copyright © 2019 Chatziaggelou, Sakkas, Votino, Papagianni and Mastorakos.
Similar articles
-
Getting pregnant with congenital adrenal hyperplasia: Assisted reproduction and pregnancy complications. A systematic review and meta-analysis.Front Endocrinol (Lausanne). 2022 Aug 31;13:982953. doi: 10.3389/fendo.2022.982953. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120452 Free PMC article.
-
[Congenital adrenal hyperplasia].Med Pregl. 1999 Nov-Dec;52(11-12):447-54. Med Pregl. 1999. PMID: 10748766 Review. Croatian.
-
Classic congenital adrenal hyperplasia and its impact on reproduction.Fertil Steril. 2019 Jan;111(1):7-12. doi: 10.1016/j.fertnstert.2018.11.037. Fertil Steril. 2019. PMID: 30611420 Review.
-
Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.BMJ Case Rep. 2020 Sep 29;13(9):e233942. doi: 10.1136/bcr-2019-233942. BMJ Case Rep. 2020. PMID: 32994263 Free PMC article.
-
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.Steroids. 2012 Mar 10;77(4):342-6. doi: 10.1016/j.steroids.2011.12.009. Epub 2011 Dec 13. Steroids. 2012. PMID: 22186144 Free PMC article. Review.
Cited by
-
Getting pregnant with congenital adrenal hyperplasia: Assisted reproduction and pregnancy complications. A systematic review and meta-analysis.Front Endocrinol (Lausanne). 2022 Aug 31;13:982953. doi: 10.3389/fendo.2022.982953. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120452 Free PMC article.
-
Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.Front Endocrinol (Lausanne). 2022 Mar 29;13:834549. doi: 10.3389/fendo.2022.834549. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35422767 Free PMC article. Review.
-
Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report.BMC Endocr Disord. 2022 Mar 7;22(1):57. doi: 10.1186/s12902-022-00969-w. BMC Endocr Disord. 2022. PMID: 35255871 Free PMC article.
-
A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?Front Endocrinol (Lausanne). 2022 Feb 24;13:813188. doi: 10.3389/fendo.2022.813188. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282449 Free PMC article.
-
Rare nonclassic type of Congenital adrenal hyperplasia due to 21-hydroxylase deficiency and genotype-phenotypic correlation.Heliyon. 2024 Feb 24;10(5):e27042. doi: 10.1016/j.heliyon.2024.e27042. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38439885 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources